Hainan Shuangcheng Pharmaceuticals Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001K63
CNY
9.58
0.46 (5.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
275.66
168.44
233.93
271.73
317.00
262.26
338.82
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
275.66
168.44
233.93
271.73
317.00
262.26
338.82
Raw Material Cost
154.22
113.87
84.54
129.20
119.13
98.65
133.08
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
33.75
45.02
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
9.68
9.27
9.62
11.24
9.84
10.43
10.28
Selling and Distribution Expenses
87.51
114.38
171.74
167.84
231.54
217.35
241.77
Other Expenses
-3.62
-4.25
-0.27
0.19
-0.05
-0.00
0.06
Total Expenditure (Excl Depreciation)
249.01
240.09
263.19
310.22
360.05
326.39
385.75
Operating Profit (PBDIT) excl Other Income
26.7
-71.6
-29.3
-38.5
-43
-64.1
-46.900000000000006
Other Income
3.19
3.92
13.01
48.74
19.10
4.61
68.07
Operating Profit (PBDIT)
75.65
-12.39
30.11
63.03
24.97
-0.68
81.11
Interest
9.68
9.27
9.62
11.24
9.84
10.43
10.28
Exceptional Items
-2.70
-29.05
-39.41
-2.15
0.00
-9.38
0.00
Gross Profit (PBDT)
121.44
54.57
149.39
142.53
197.87
163.62
205.74
Depreciation
55.10
55.46
54.05
58.52
55.49
58.29
60.31
Profit Before Tax
8.16
-106.17
-72.97
-8.88
-40.36
-78.78
10.52
Tax
-0.76
0.10
-0.99
-0.38
0.45
1.17
1.49
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
19.04
-78.30
-50.74
9.01
-20.33
-53.33
24.66
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
19.04
-78.30
-50.74
9.01
-20.33
-53.33
24.66
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-10.12
-27.96
-21.23
-17.51
-20.48
-26.62
-15.63
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
8.92
-106.27
-71.98
-8.50
-40.81
-79.95
9.03
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
412.46
393.41
471.49
513.55
481.85
492.93
546.26
Earnings per share (EPS)
0.05
-0.19
-0.12
0.02
-0.05
-0.13
0.06
Diluted Earnings per share
0.05
-0.19
-0.12
0.02
-0.05
-0.13
0.06
Operating Profit Margin (Excl OI)
6.29%
-42.61%
-15.79%
-16.28%
-15.65%
-24.24%
-13.95%
Gross Profit Margin
22.95%
-30.11%
-8.09%
18.27%
4.77%
-7.81%
20.9%
PAT Margin
6.91%
-46.49%
-21.69%
3.32%
-6.41%
-20.33%
7.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 63.72% vs -28.00% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 108.37% vs -47.64% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 544.79% vs -195.32% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 4.30% vs -3.12% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Hainan Shuangcheng Pharmaceuticals Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
275.66
0
275.66
Other Operating Income
0.00
0.00
0.00
Total Operating income
275.66
0
275.66
Raw Material Cost
154.22
0
154.22
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
33.75
0
33.75
Power Cost
0
0
0.00
Manufacturing Expenses
9.68
0
9.68
Selling and Distribution Expenses
87.51
0
87.51
Other Expenses
-3.62
0.00
-3.62
Total Expenditure (Excl Depreciation)
249.01
0
249.01
Operating Profit (PBDIT) excl Other Income
26.66
0.00
26.66
Other Income
3.19
0
3.19
Operating Profit (PBDIT)
75.65
0
75.65
Interest
9.68
0
9.68
Exceptional Items
-2.70
0
-2.70
Gross Profit (PBDT)
121.44
0
121.44
Depreciation
55.10
0
55.10
Profit Before Tax
8.16
0
8.16
Tax
-0.76
0
-0.76
Provisions and contingencies
0
0
0.00
Profit After Tax
19.04
0
19.04
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
19.04
0
19.04
Share in Profit of Associates
0
0
0.00
Minority Interest
-10.12
0
-10.12
Other related items
0.00
0.00
0.00
Consolidated Net Profit
8.92
0
8.92
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
412.46
0
412.46
Earnings per share (EPS)
0.05
0
0.05
Diluted Earnings per share
0.05
0
0.05
Operating Profit Margin (Excl OI)
6.29%
0%
0.00
6.29%
Gross Profit Margin
22.95%
0%
0.00
22.95%
PAT Margin
6.91%
0%
0.00
6.91%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 27.57 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 63.72% vs -28.00% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 0.89 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 108.37% vs -47.64% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.25 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 544.79% vs -195.32% in Dec 2024

Annual - Interest
Interest 0.97 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 4.30% vs -3.12% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.29%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024